Verificando…
Traduzido automaticamente. Doses e advertências: confira o original em inglês. Ler em inglês
Início / Registado na Nigéria / Primolut Depot

Primolut Depot

NAFDAC Reg. No. 04-5047 · Drug

Registered with NAFDAC. Registration activeAs of 4 November 2026 · synced automatically from official sources.
Product
Primolut Depot
Número NAFDAC
04-5047
Princípio ativo
Hydroxyprogesterone caproate
Dosagem
250 mg/mL
Forma
Solution for injection
Tamanho da embalagem
1 mL x 1's (in ampoule)
Manufacturer
Not listed
Applicant (holder)
Bayer Nigeria Limited
Approved
26 Aug 2021
Situação
Inactive View on NAFDAC ↗
Registro válido até
25 Aug 2026
Alertas da OMS
None found
Community reports
None
Times checked
0

About the medicine: Hydroxyprogesterone caproate: uses, dosage and brands worldwide

What we found

  • Primolut Depot is on the NAFDAC register with an active registration (04-5047). A valid number alone does not prove a pack is genuine — counterfeiters copy real numbers, so also check the expiry date, seal and print quality.

Generated automatically from the NAFDAC register, WHO alerts and community data as of today. This is not medical advice. Always follow your doctor or pharmacist.

How to use Primolut Depot

O que diz a bula oficial. Se um médico receitou, siga a receita. Se a bula da sua caixa for diferente, vale a da sua caixa.

Para quem é

Hydroxyprogesterone Caproate Injection, USP is indicated in non-pregnant women: for the treatment of advanced adenocarcinoma of the uterine corpus (Stage III or IV); in the management of amenorrhea (primary and secondary) and abnormal uterine bleeding due to hormonal imbalance in the absence of organic pathology, such as submucous fibroids or uterine cancer; as a test for endogenous estrogen production and for the production of secretory endometrium and desquamation.

Como tomar e com que frequência
  • Suggested dosages are presented in the therapy guide
  • Because of the low viscosity of the vehicle, Hydroxyprogesterone Caproate Injection, USP may be administered with a small gauge needle
  • Care should be taken to inject the preparation deeply into the upper outer quadrant of the gluteal muscle following the usual precautions for intramuscular injection
  • Since the 250 mg potency provides a high concentration in a small volume, particular care should be observed to administer the full dose
  • Note: Use of a wet needle or syringe may cause the solution to become cloudy; however, this does not affect the potency of the material
  • Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration, whenever solution and container permit
  • Protect from light
  • Store vial in its box
  • Store upright
  • Discard any unused product within 5 weeks after first use
  • THERAPY GUIDE CYCLIC THERAPY SCHEDULE: (28-day cycle; repeated every 4 weeks); Day 1 of each cycle: 20 mg Estradiol Valerate Injection, USP 2 weeks after Day 1: 250 mg Hydroxyprogesterone Caproate Injection, USP and 5 mg Estradiol Valerate Injection, USP 4 weeks after Day 1
  • This is Day 1 of next cycle SUGGESTED CYCLIC REGIMEN Indications Dosage Started Repeated Stopped Comments Amenorrhea (primary and secondary): Abnormal uterine bleeding due to hormonal imbalance in the absence of organicpathology, such as submucous fibroids or uterine cancer. 375 mg Any time - - Genital malignancy should be excluded before hormone therapy is started. …
While you are taking it
  • Information for The Patient Counsel patients that hydroxyprogesterone caproate injections may cause pain, soreness, swelling, itching or bruising
  • Inform the patient to contact her physician if she notices increased discomfort over time, oozing of blood or fluid, or inflammatory reactions at the injection site
Talk to a doctor first if
  • Hydroxyprogesterone caproate is contraindicated in patients with known or suspected carcinoma of the breast, other hormone-sensitive cancer, or history of these conditions; undiagnosed abnormal vaginal bleeding; liver dysfunction or disease; missed abortion, and in those with a history of hypersensitivity to the drug
  • Hydroxyprogesterone caproate is also contraindicated as a diagnostic test for pregnancy and in patients with current or history of thrombotic or thromboembolic disorders
Warnings

Thrombotic and Thromboembolic Events Discontinue the medication pending examination if there is a sudden partial or complete loss of vision or if there is a sudden onset of proptosis, diplopia, or migraine. Medication should be stopped if examination reveals papilledema or retinal vascular lesions. Allergic reactions Hypersensitivity reaction to progestins have been reported. Hydroxyprogesterone caproate is contraindicated in women with a history of hypersensitivity to a progestin. Glucose tolerance Progestins may decrease glucose tolerance and the blood glucose concentration should be monitored in diabetic users.

Possíveis efeitos colaterais

A. Serious arterial thrombotic and venous thromboembolic events, including cases of pulmonary emboli (some fatal), deep vein thrombosis, myocardial infarction, and strokes, have been reported in women using progestins. B. neuroocular lesions (e.g., retinal thrombosis and optic neuritis); nausea; vomiting; gastrointestinal symptoms (such as abdominal cramps or bloating); edema; breakthrough bleeding, spotting, or withdrawal bleeding; breast tenderness; changes in body weight (increase or decrease); headache; increase in cervical mucus; allergic rash; abscess; pain at the injection site; migraine headaches. C. …

Se esquecer uma dose

Tome assim que lembrar, a menos que esteja quase na hora da próxima dose. Nesse caso, pule a dose esquecida. Nunca tome duas doses de uma vez para compensar. Confira a bula, pois alguns medicamentos são diferentes.

From the official U.S. FDA label for this active ingredient. Your pack may have a different strength, so always read its leaflet. If a doctor prescribed it, follow the prescription. Ask a pharmacist if you are unsure. Label dated 2026-06-12.

Label for hydroxyprogesterone caproate, the active ingredient registered with NAFDAC.

Check your pack of Primolut Depot

Add the expiry date on your pack for a full Trust Score.

Ou tire fotos da caixa
Restam 3 verificações grátis hoje Official sources: U.S. FDA · EMA (EU) · Health Canada · WHO alerts

About Primolut Depot

What is in Primolut Depot?

Primolut Depot contains Hydroxyprogesterone caproate (250 mg/mL), as solution for injection, according to its NAFDAC registration record.

Is Primolut Depot registered with NAFDAC?

Yes. Primolut Depot is listed on the NAFDAC register under registration number 04-5047, and its registration is active as of 4 November 2026.

Has Primolut Depot been flagged as fake or recalled?

No WHO falsified or substandard medical product alert currently matches Primolut Depot in our automatically synced alert list.

How can I check that my pack of Primolut Depot is genuine?

Run a free authenticity scan with the NAFDAC number 04-5047, your pack's expiry date and batch number to get a Trust Score, compare the pack with the NAFDAC record (ingredient, strength, form, manufacturer), and buy only from licensed pharmacies.

How do I take Primolut Depot?

Follow your prescription or the leaflet in your pack. The official label says: Suggested dosages are presented in the therapy guide. Because of the low viscosity of the vehicle, Hydroxyprogesterone Caproate Injection, USP may be administered with a small gauge needle. Care should be taken to inject the preparation deeply into the upper outer quadrant of the gluteal muscle following the usual precautions for intramuscular injection. Since the 250 mg potenc…

What is Primolut Depot used for?

Hydroxyprogesterone Caproate Injection, USP is indicated in non-pregnant women: for the treatment of advanced adenocarcinoma of the uterine corpus (Stage III or IV); in the management of amenorrhea (primary and secondary) and abnormal uterine bleeding due to hormonal imbalance in the absence of organic pathology, such as submucous fibroids or uterine cancer; as a test for endogenous estrogen produ (Summarised from the official U.S. FDA label for hydroxyprogesterone caproate. Always follow your doctor or pharmacist.)

Patient reviews

–No reviews yet
5★
0
4★
0
3★
0
2★
0
1★
0
Have you used Primolut Depot? Share your experience to help other patients. Sign in to review

Reviews are personal experiences from PillVera users, not medical advice. Report side effects to your doctor and to NAFDAC.